CHM.CN Stock Surges 900% in May 2026 as Waverunner Capital Gains Momentum

CHM.CN stock exploded with a 900% gain on May 4, 2026, reaching C$0.05 per share as Waverunner Capital Inc. captures investor attention. The venture capital firm, formerly known as Chemistree Technology Inc., rebranded in June 2024 to focus on early-stage investments across Europe and North America. Trading on the CNQ exchange, CHM.CN stock has climbed from a previous close of C$0.005, signaling renewed market interest. The company specializes in seed funding, bridge financing, and growth capital across healthcare, renewable energy, and biotechnology sectors. This dramatic price movement reflects shifting investor sentiment toward venture capital opportunities in emerging markets.

CHM.CN Stock Price Action and Market Momentum

CHM.CN stock’s 900% surge represents one of the most dramatic single-day moves for the venture capital firm. The stock climbed from C$0.005 to C$0.05, marking a C$0.045 gain in absolute terms. Trading volume remained modest, with average daily volume around 28,908 shares, suggesting the move reflects concentrated buying interest rather than broad retail participation.

The 50-day moving average sits at C$0.0424, while the 200-day average rests at C$0.0481. This positions the current price above both key technical levels, indicating potential bullish momentum. Year-to-date performance shows the stock trading near its 52-week low of C$0.05, with a year high of C$0.10. The market cap stands at approximately C$37.2 million based on 744.2 million shares outstanding.

Waverunner Capital’s Business Model and Investment Strategy

Waverunner Capital Inc. operates as a specialized venture capital firm targeting early-stage companies across multiple sectors. The company seeks equity investments between C$500,000 and C$1 million, focusing on enterprises valued between C$2 million and C$5 million. Based in North Vancouver, British Columbia, the firm invests through its own balance sheet and personal capital, providing flexibility in deal structuring.

The company’s portfolio spans renewable energy (wind and solar), plant-based wellness, consumer-targeted biotechnology, and resource sectors. CEO Karl Eric Kottmeier leads the organization, which was founded in 2008. Waverunner’s rebranding from Chemistree Technology signals a strategic pivot toward venture capital as its core business, moving away from its previous focus. This repositioning aligns with growing demand for early-stage funding in innovation-driven sectors across North America and Europe.

Financial Metrics and Valuation Considerations

CHM.CN stock trades at a negative P/E ratio of -5.0, reflecting the company’s current unprofitability. Net income per share stands at -C$0.0595, indicating ongoing losses. The company reported negative operating cash flow of -C$0.0045 per share, suggesting cash burn from operations. However, the firm maintains C$0.0080 in cash per share, providing a liquidity buffer for operations and investments.

Key balance sheet metrics reveal challenges: the current ratio of 0.097 indicates potential short-term liquidity concerns, while the debt-to-equity ratio of -0.629 reflects negative shareholder equity. Book value per share is -C$0.1422, a red flag for value investors. Despite these headwinds, track CHM.CN on Meyka for real-time updates on financial developments. The enterprise value of C$37.6 million suggests the market values the company’s venture capital portfolio and future investment potential.

Market Sentiment and Trading Activity

The 900% price surge reflects a dramatic shift in market sentiment toward CHM.CN stock. Trading activity concentrated around the C$0.05 level, with both day low and day high matching this price point. Average volume of 28,908 shares suggests institutional or informed retail accumulation rather than panic buying.

Meyka AI rates CHM.CN with a grade of B, suggesting a HOLD recommendation. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating reflects balanced risk-reward dynamics despite current financial challenges. Investors should note these grades are not guaranteed and we are not financial advisors. The venture capital sector remains attractive for growth-oriented portfolios, though CHM.CN’s specific financial position warrants careful due diligence before investment decisions.

Final Thoughts

CHM.CN’s 900% gain reflects venture capital volatility and opportunity. Waverunner Capital trades at depressed valuations with negative earnings, appealing to contrarian investors. Its rebranding and focus on renewable energy and biotech investments offer growth potential if portfolio companies succeed. However, weak balance sheet and liquidity concerns require careful monitoring. The stock remains highly speculative, suitable only for risk-tolerant investors who believe in the company’s investment strategy and can withstand significant losses.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.